[Evaluation of amikacin in gynecological and obstetric field (author's transl)].
D000328:Adult; D003556:Cystitis / Q000188:drug therapy; D004755:Enterobacteriaceae / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006801:Humans; D007612:Kanamycin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D007709:Klebsiella / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy; D010538:Peritonitis / Q000188:drug therapy; D011511:Proteus / Q000187:drug effects; D011513:Proteus mirabilis / Q000187:drug effects; D011702:Pyelitis / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D014847:Vulvitis / Q000188:drug therapy
D007612:Kanamycin